Cencora, Inc. (NYSE:COR) Announces Quarterly Dividend of $0.60

Cencora, Inc. (NYSE:COR) announced a quarterly dividend on Wednesday, May 6th. Stockholders of record on Friday, May 15th will be given a dividend of 0.60 per share on Monday, June 1st. This represents a c) dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, May 15th.

Cencora has raised its dividend payment by an average of 0.1%per year over the last three years and has raised its dividend every year for the last 15 years. Cencora has a dividend payout ratio of 13.9% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Cencora to earn $19.59 per share next year, which means the company should continue to be able to cover its $2.40 annual dividend with an expected future payout ratio of 12.3%.

Cencora Stock Performance

Shares of COR traded down $52.71 during midday trading on Wednesday, reaching $253.20. 7,858,017 shares of the stock were exchanged, compared to its average volume of 1,418,244. The business’s 50-day moving average price is $332.27 and its 200 day moving average price is $343.21. The company has a debt-to-equity ratio of 3.62, a current ratio of 0.92 and a quick ratio of 0.51. Cencora has a twelve month low of $244.82 and a twelve month high of $377.54. The company has a market capitalization of $49.25 billion, a price-to-earnings ratio of 30.43, a PEG ratio of 1.42 and a beta of 0.64.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.80 by ($0.05). Cencora had a return on equity of 176.54% and a net margin of 0.50%.The firm had revenue of $78.36 billion for the quarter, compared to analyst estimates of $81.09 billion. During the same quarter last year, the firm posted $4.42 EPS. The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, sell-side analysts expect that Cencora will post 17.58 EPS for the current fiscal year.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.